Published in J Pediatr on February 01, 2003
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol (2014) 2.09
Retracted Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysis. PLoS One (2014) 1.41
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child (2003) 0.96
Treatment of atopic dermatitis with pimecrolimus - impact on quality of life. Ther Clin Risk Manag (2007) 0.92
A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. MedGenMed (2006) 0.81
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol (2015) 0.81
Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use. Postepy Dermatol Alergol (2013) 0.79
Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol (2003) 0.78
Pimecrolimus cream in the management of patients with atopic eczema. Clin Cosmet Investig Dermatol (2009) 0.75
Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand Dermatitis. J Pediatr Pharmacol Ther (2016) 0.75
Study of the Atopic March: Development of Atopic Comorbidities. Pediatr Dermatol (2016) 0.75
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol (2002) 2.41
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 2.18
A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet (2009) 1.91
Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol (2010) 1.89
Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med (2002) 1.75
Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet (2011) 1.60
ENU mutagenesis, a way forward to understand gene function. Annu Rev Genomics Hum Genet (2008) 1.59
Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J (2012) 1.58
Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol (2004) 1.55
Role of shunt surgery in pediatric tubercular meningitis with hydrocephalus. Indian Pediatr (2005) 1.50
Oligonucleotides suppress IL-8 in skin keratinocytes in vitro and offer anti-inflammatory properties in vivo. J Invest Dermatol (2006) 1.48
Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci (2006) 1.47
Esophagectomies with thoracic incisions carry increased pulmonary morbidity. JAMA Surg (2013) 1.45
Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol (2008) 1.44
Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? J Dtsch Dermatol Ges (2006) 1.43
[Subcutaneous sarcoidosis as the first manifestation of systemic disease]. Actas Dermosifiliogr (2006) 1.42
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy (2012) 1.41
Metronomic low-dose chemotherapy as antiangiogenic therapeutic strategy for cancer. J Dtsch Dermatol Ges (2005) 1.40
DTI registration in atlas based fiber analysis of infantile Krabbe disease. Neuroimage (2011) 1.38
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol (2004) 1.37
Pancreatic panniculitis. Dermatol Clin (2008) 1.36
Pediatric intracranial aneurysms-clinical characteristics and outcome of surgical treatment. Childs Nerv Syst (2006) 1.34
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33
PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation. Circ Res (2003) 1.33
Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease. J Cutan Pathol (2002) 1.32
Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol (2011) 1.32
Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res (2004) 1.30
Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet (2011) 1.30
MGMT gene promoter methylation in pediatric glioblastomas. Childs Nerv Syst (2010) 1.29
Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol (2002) 1.29
Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model. Neoplasia (2006) 1.24
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics (2002) 1.22
Mechanical stretch stimulates protein kinase B/Akt phosphorylation in epidermal cells via angiotensin II type 1 receptor and epidermal growth factor receptor. J Biol Chem (2004) 1.19
The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol (2008) 1.18
Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: evidence for anti-angiogenic action. J Invest Dermatol (2011) 1.17
Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology (2008) 1.15
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood (2007) 1.14
Spontaneous isolated superior mesenteric artery dissection: a case report and literature review with management algorithm. Ann Vasc Surg (2009) 1.12
Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem (2007) 1.12
Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol (2004) 1.11
High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet (2013) 1.11
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol (2005) 1.10
Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology (2002) 1.06
Dermatological diagnostic acumen improves with use of a simple telemedicine system for underserved areas of South Africa. Telemed J E Health (2011) 1.06
Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int J Oncol (2006) 1.06
Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet (2010) 1.05
Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial. Dermatology (2011) 1.05
IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol (2012) 1.04
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Res (2007) 1.04
Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology (2005) 1.03
Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest (2002) 1.02
Brain abscess due to Enterococcus avium. Am J Med Sci (2005) 1.01
Identification of specific protein markers in microdissected hepatocellular carcinoma. J Proteome Res (2007) 1.01
Down-regulation of MTUS1 in human colon tumors. Oncol Rep (2010) 1.01
The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost (2006) 1.00
A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol (2007) 1.00
Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol (2012) 0.99
Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis. J Am Soc Hypertens (2010) 0.98
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol (2003) 0.98
Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicol In Vitro (2008) 0.98
Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci (2003) 0.97
Spinal dural arterio-venous fistula: clinico-radiological profile and outcome following surgical occlusion in an Indian neurosurgical center. Neurol India (2013) 0.96
Surgical management of giant intracranial aneurysms. Clin Neurol Neurosurg (2008) 0.96
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res (2008) 0.96
Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res (2008) 0.95
Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding. FEBS Lett (2003) 0.95
Dimethyl fumarate - only an anti-psoriatic medication? J Dtsch Dermatol Ges (2012) 0.95
A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet (2013) 0.95
Tropical rat mites (Ornithonyssus bacoti) - serious ectoparasites. J Dtsch Dermatol Ges (2009) 0.95
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Hum Mol Genet (2012) 0.95
Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light. J Invest Dermatol (2007) 0.94
Clonality in juvenile xanthogranuloma. Am J Surg Pathol (2007) 0.94
Intramedullary subependymoma of the spinal cord: a case report and review of literature. Clin Neurol Neurosurg (2003) 0.94
Short German guidelines: malignant melanoma. J Dtsch Dermatol Ges (2008) 0.94
Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene. Eur J Endocrinol (2005) 0.93
Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing. Contact Dermatitis (2002) 0.93
Age-related changes in speed and mechanism of adult skeletal muscle stem cell migration. Stem Cells (2012) 0.93
Role of the epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges (2009) 0.93
Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model. Int J Cancer (2009) 0.93
Association of craniovertebral and upper cervical anomalies with dermoid and epidermoid cysts: report of four cases. Neurosurgery (2005) 0.92
Meningioangiomatosis with meningioma: an uncommon association of a rare entity--report of a case and review of the literature. Childs Nerv Syst (2005) 0.92
PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanism. Oncol Res (2004) 0.92
Diffusion imaging quality control via entropy of principal direction distribution. Neuroimage (2013) 0.92
Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. Dermatology (2007) 0.92
Gamma knife radiosurgery for arteriovenous malformations of basal ganglia, thalamus and brainstem--a retrospective study comparing the results with that for AVMs at other intracranial locations. Acta Neurochir (Wien) (2009) 0.92
Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation (2002) 0.91
Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study. Cancer Chemother Pharmacol (2003) 0.91
Protective effect of methylprednisolone on warm ischemia-reperfusion injury in a cholestatic rat liver. Am J Surg (2010) 0.91
The double hatchet flap as a potential alternative closure technique for scalp defects. J Dtsch Dermatol Ges (2015) 0.91
Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression. J Invest Dermatol (2007) 0.91
Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges (2008) 0.91
Necessity for improvement in endoscopy training during surgical residency. Am J Surg (2010) 0.90
Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells. Cancer Res (2009) 0.90
Microtubule-targeted drugs inhibit VEGF receptor-2 expression by both transcriptional and post-transcriptional mechanisms. J Invest Dermatol (2008) 0.89
Mechanical stretch induces clustering of beta1-integrins and facilitates adhesion. Exp Dermatol (2006) 0.89
PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration. Oncol Rep (2006) 0.89
Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol (2012) 0.88
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study. J Am Acad Dermatol (2005) 0.88